The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IWWM-11 2022 | Risk stratification models for smoldering WM and strategies to improve these
Irene Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA, briefly discusses risk stratification models for smoldering Waldenström’s macroglobulinemia (WM), and emphasizes the value of adding genomic information to these models and further investigating the immune system to improve methods of risk stratification. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
